News & Insights

Johnson & Johnson Impact Ventures invests in VIEBEG Medical to strengthen medical supply chains in Africa

New Impact Investment banners - New Brand_v1_Viebeg_web.png New Impact Investment banners - New Brand_v1_Viebeg_web.png

Throughout many parts of Africa, healthcare systems and providers face challenges keeping key medical equipment and supplies in stock—or even procuring them in the first place. This contributes to a lack of access to important diagnostic and therapeutic procedures, ultimately leading to preventable deaths and other negative health outcomes for patients in under-resourced communities.

Founded in 2018 by CEO Tobias Reiter and Chief Commercial Officer Alex Musyoka, VIEBEG Medical works with hospitals, clinics and healthcare providers to manage and expand their supply of medical products, devices and equipment critical to meeting the full range of patient needs. VIEBEG has strengthened these providers’ resilience against external shocks, such as climate disasters and civil unrest, allowing them to avoid shortages and protect their patients’ access to essential care.

VIEBEG has built a digital platform that serves as a one-stop-shop for supply chain and logistics services, including ordering, shipping, warehousing, last-mile distribution and inventory management. The company supports healthcare partners at every step with the help of sophisticated AI-powered software that organizes data on regional health demands, supply trends and patient demographics. VIEBEG also ensures affordability, offering crucial financing support through flexible payment plans and financing partners. Since its launch, VIEBEG has successfully helped over 500 health providers with care to more than 900,000 patients.

“When medical supply chains fail, providers have limited ability to give care to their patients, leading to poor health outcomes. At VIEBEG, we are combating that with comprehensive services and AI-powered insights. When providers have all the equipment and supplies they need, they can better meet their patients’ needs—the ultimate goal.” - Tobias Reiter, Co-Founder and CEO of VIEBEG

Johnson & Johnson Impact Ventures, an impact fund within the Johnson & Johnson Foundation, invested in VIEBEG Medical in 2023. Our investment supports VIEBEG plans to reach more providers and patients through continued growth and expansion in East and Central Africa – in Rwanda, Kenya and the Democratic Republic of Congo.

“Reliable supply of essential medical products is one of the most fundamental aspects of a health provider’s success. We are excited to support and grow VIEBEG’s vital work in this space, strengthening the ability of health systems to provide care to their patients.” – David Higgins, Investments Director at J&J Impact Ventures